Insider Transactions in Q3 2022 at Intra Cellular Therapies, Inc. (ITCI)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2022
|
Robert L Van Nostrand |
BUY
Grant, award, or other acquisition
|
Direct |
110
+1.19%
|
$5,060
$46.53 P/Share
|
|
Sep 30
2022
|
Rory B Riggs |
BUY
Grant, award, or other acquisition
|
Direct |
365
+0.47%
|
$16,790
$46.53 P/Share
|
|
Sep 21
2022
|
Lawrence J. Hineline SVP of Finance, CFO |
SELL
Open market or private sale
|
Direct |
65,164
-74.45%
|
$2,932,380
$45.64 P/Share
|
|
Sep 21
2022
|
Lawrence J. Hineline SVP of Finance, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
65,164
+50.0%
|
$977,460
$15.47 P/Share
|
|
Aug 11
2022
|
Robert L Van Nostrand |
SELL
Open market or private sale
|
Direct |
30,000
-43.61%
|
$1,680,000
$56.98 P/Share
|
|
Aug 11
2022
|
Robert L Van Nostrand |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+30.59%
|
$360,000
$12.75 P/Share
|
|
Aug 11
2022
|
Joel S Marcus |
SELL
Open market or private sale
|
Direct |
10,000
-18.44%
|
$590,000
$59.22 P/Share
|